Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Regeneron Pharmaceuticals Inc (REGN)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 17
  • 1 comments

(71% Positive) REGENERON PHARMACEUTICALS, INC. (REGN) Reports 131% Profit Growth for 2022-06-30

Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 19
  • 1 comments

(28% Negative) Aclaris Therapeutics, Inc. (ACRS) Reports Net Loss for 2022-06-30

Comment Full text

Veracyte Inc (VCYT)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 19
  • 1 comments

(28% Negative) VERACYTE, INC. (VCYT) Reports 112% Loss Increase for 2022-06-30

Comment Full text

Morphic Therapeutic (MORF)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 21
  • 1 comments

(28% Negative) MORPHIC HOLDING, INC. (MORF) Reports 957% Loss Increase for 2022-06-30

Comment Full text

Seres Therapeutics Inc (MCRB)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 18
  • 1 comments

(75% Positive) Seres Therapeutics, Inc. (MCRB) Reports 31% Loss Reduction for 2022-06-30

Comment Full text

Pacira BioSciences Inc (PCRX)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 23
  • 1 comments

(51% Neutral) PACIRA BIOSCIENCES, INC. (PCRX) Reports Profit for 2022-06-30

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 23
  • 1 comments

(75% Positive) Lexicon Pharmaceuticals, Inc. (LXRX) Reports Net Loss for 2022-06-30

Comment Full text

Summit Plc (SMMT)

  • Event
  • Aug. 02, 2022, 21:09 UTC
  • 22
  • 1 comments

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Clinical Trial Timeline Adjustment

Comment Full text

Puma Biotechnology Inc (PBYI)

  • Event
  • Aug. 02, 2022, 20:47 UTC
  • 21
  • 1 comments

(99% Neutral) PUMA BIOTECHNOLOGY, INC. (PBYI) Announces New Board Appointment

Comment Full text

Apellis Pharmaceuticals Inc (APLS)

  • Event
  • Aug. 02, 2022, 20:38 UTC
  • 22
  • 1 comments

(99% Neutral) Apellis Pharmaceuticals, Inc. (APLS) Announces Business Combination

Comment Full text
  • Previous
  • 538
  • 539
  • 540
  • 541
  • 542
  • Next

Search

News categories

  • Technical Exchange News(12475)
  • Event(6229)
  • SEC News(283203)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(161747)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin